MARK CRAWSHAW: Open Payments
NPI 1265009559 · MOUNT VERNON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $164 |
| Incyte Corporation | 2 | $55 |
| Organon LLC | 4 | $53 |
| LEO Pharma Inc. | 2 | $51 |
| Janssen Biotech, Inc. | 2 | $43 |
| GENZYME CORPORATION | 1 | $34 |
| Amgen Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Biocon Biologics Inc | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: RINVOQ, OPZELURA, TREMFYA, DUPIXENT, Otezla, LIBTAYO, ADBRY, VTAMA.
Industry payments across WA — which companies pay providers there.
